[1] YU X, ZHOU S, WANG J, et al.Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies[J]. Breast Cancer, 2017, 24(5):1-15.
[2] FAN L, STRASSER-WEIPPL K, LI J J, et al.Breast cancer in China[J]. Lancet Oncology, 2014, 15(7):279-289.
[3] HASLAM S Z.Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors[J]. Journal of Steroid Biochemistry, 1988, 31(1):9-13.
[4] GEBBIE A.Risks and benefits of estrogen plus progestin in healthy postmenopausal women[J]. Journal of Family Planning & Reproductive Health Care, 2002, 28(4):221.
[5] JONES M E, SCHOEMAKER M J, LAUREN W, et al.Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?[J]. British Journal of Cancer, 2016, 115(5):607-615.
[6] HOFSETH L J, RAAFAT A M, OSUCH J R, et al.Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast[J]. Journal of Clinical Endocrinology & Metabolism, 1999, 84(12):4559.
[7] RAAFAT A M, LI S, BENNETT J M, et al.Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model[J]. Journal of Cellular Physiology, 2015, 187(1):81-89.
[8] LÓPEZOTÍN C, BLASCO M A, PARTRIDGE L, et al. The hallmarks of aging[J]. Cell, 2013, 153(6):1194-1217.
[9] Hanahan D, Weinberg R A.The hallmarks of cancer[J]. Cell,2000,100(1):57-70.
[10] 中华医学会妇产科学分会绝经学组. 绝经过渡期和绝经后期激素补充治疗临床应用指南(2009版)[J]. 柳州医学, 2011, 45(3):635-638.
[11] WITT-ENDERBY P A, SLATER J P, JOHNSON N A, et al. Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice[J]. Journal of Pineal Research, 2012, 53(4):374.
[12] 黄凌曦. 激素替代治疗与乳腺癌发病风险的关系[J]. 中华乳腺病杂志(电子版), 2011, 5(1):45-47.
[13] DAI J, JIAN J, BOSLAND M, et al.Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status[J]. Breast, 2008, 17(2):172.
[14] EMERY L A, TRIPATHI A, KING C, et al.Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression[J]. American Journal of Pathology, 2009, 175(3):1292-1302.
[15] 荣玮. 定量分析在乳腺非典型增生与乳腺癌鉴别中的应用[J]. 中国基层医药, 2003, 10(7):683-683.
[16] HONETH G, LOMBARDI S, GINESTIER C, et al.Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium[J]. Breast Cancer Research, 2014, 16(3):R52.
[17] ARENDT L M, KUPERWASSER C.Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy[J]. Journal of Mammary Gland Biology & Neoplasia, 2015, 20(1/2):9-25. |
